• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外将负载依非韦伦的促吞噬肽共轭聚(丙烯亚胺)树枝状大分子靶向至HIV感染的巨噬细胞

Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro.

作者信息

Dutta Tathagata, Garg Minakshi, Jain Narendra K

机构信息

Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar, M.P. 470003, India.

出版信息

Eur J Pharm Sci. 2008 Jul 3;34(2-3):181-9. doi: 10.1016/j.ejps.2008.04.002. Epub 2008 Apr 18.

DOI:10.1016/j.ejps.2008.04.002
PMID:18501568
Abstract

HIV infected macrophages are considered as reservoirs for spreading the virus in AIDS patients. Tuftsin not only binds specifically to the mononuclear phagocytic cells but also enhances their natural killer activity. The purpose of this study is to explore the targeting potential and anti-HIV activity of efavirenz (EFV) loaded, tuftsin conjugated 5th generation poly(propyleneimine) dendrimers (TuPPI) in vitro. Tuftsin was chemically conjugated to 5th generation poly(propyleneimine) dendrimers (PPI). The entrapment efficiency of PPI and TuPPI were found to be 37.43+/-0.3% and 49.31+/-0.33%, respectively. TuPPI was found to slow down and prolong the in vitro release of EFV upto 144h against PPI, which releases the drug completely within 24 h. TuPPI possessed negligible cytotoxicity as compared to that of PPI. The cellular uptake of TuPPI was found to be 34.5 times higher than that of the free drug in first 1 h and was significantly higher in HIV infected macrophages than that of uninfected cells. TuPPI was found to reduce the viral load by 99% at a concentration of 0.625 ng/ml, which is due to the enhanced cellular uptake, reduced toxicity and the inherent anti-HIV activity of TuPPI.

摘要

HIV感染的巨噬细胞被认为是艾滋病患者体内病毒传播的储存库。促吞噬素不仅能特异性结合单核吞噬细胞,还能增强其天然杀伤活性。本研究的目的是在体外探索负载依法韦仑(EFV)、缀合促吞噬素的第五代聚(丙烯亚胺)树枝状大分子(TuPPI)的靶向潜力和抗HIV活性。促吞噬素通过化学方法与第五代聚(丙烯亚胺)树枝状大分子(PPI)缀合。发现PPI和TuPPI的包封率分别为37.43±0.3%和49.31±0.33%。与在24小时内完全释放药物的PPI相比,TuPPI能减缓并延长EFV的体外释放长达144小时。与PPI相比,TuPPI的细胞毒性可忽略不计。发现TuPPI在最初1小时内的细胞摄取量比游离药物高34.5倍,且在HIV感染的巨噬细胞中的摄取量显著高于未感染细胞。在浓度为0.625 ng/ml时,TuPPI能将病毒载量降低99%,这归因于其增强的细胞摄取、降低的毒性以及TuPPI固有的抗HIV活性。

相似文献

1
Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro.体外将负载依非韦伦的促吞噬肽共轭聚(丙烯亚胺)树枝状大分子靶向至HIV感染的巨噬细胞
Eur J Pharm Sci. 2008 Jul 3;34(2-3):181-9. doi: 10.1016/j.ejps.2008.04.002. Epub 2008 Apr 18.
2
Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro.基于聚(丙烯亚胺)树枝状大分子的纳米容器用于在体外将依非韦伦靶向递送至人单核细胞/巨噬细胞。
J Drug Target. 2007 Jan;15(1):89-98. doi: 10.1080/10611860600965914.
3
Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.载有拉米夫定的甘露糖化聚(丙烯亚胺)树枝状大分子的靶向潜力及抗HIV活性
Biochim Biophys Acta. 2007 Apr;1770(4):681-6. doi: 10.1016/j.bbagen.2006.12.007. Epub 2006 Dec 21.
4
Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers.齐多夫定制载唾液酸偶联甘露糖化聚丙稀亚胺树枝状高分子的合成、表征及靶向性研究。
Eur J Pharm Sci. 2013 Mar 12;48(4-5):668-79. doi: 10.1016/j.ejps.2012.12.027. Epub 2013 Jan 5.
5
Interactions between U-937 human macrophages and poly(propyleneimine) dendrimers.U-937人巨噬细胞与聚(丙烯亚胺)树枝状大分子之间的相互作用。
J Control Release. 2007 Jul 16;120(1-2):51-9. doi: 10.1016/j.jconrel.2007.03.019. Epub 2007 Apr 1.
6
Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy.促吞噬素-叠氮胸苷偶联物:艾滋病治疗中潜在的巨噬细胞靶向作用。
J Pept Sci. 2005 Jan;11(1):37-44. doi: 10.1002/psc.587.
7
Effect of surface capping on targeting potential of folate decorated poly (propylene imine) dendrimers.表面封端对叶酸修饰的聚(丙烯亚胺)树枝状大分子靶向潜力的影响。
Drug Dev Ind Pharm. 2015;41(8):1393-9. doi: 10.3109/03639045.2014.954584. Epub 2014 Aug 28.
8
Formulation development and in vitro-in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector.第四代质子泵抑制剂树枝状聚合物作为癌症靶向载体的制剂开发及体内外评估
Nanomedicine (Lond). 2014 Oct;9(15):2291-308. doi: 10.2217/nnm.13.210. Epub 2014 Mar 5.
9
Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate.基于糖缀合肽树枝状大分子的纳米颗粒系统用于磷酸氯喹的递送。
Biomaterials. 2007 Aug;28(22):3349-59. doi: 10.1016/j.biomaterials.2007.04.004. Epub 2007 Apr 6.
10
Characterization and evaluation of amphotericin B loaded MDP conjugated poly(propylene imine) dendrimers.负载两性霉素B的MDP共轭聚(丙烯亚胺)树枝状大分子的表征与评价
Nanomedicine. 2015 Apr;11(3):705-13. doi: 10.1016/j.nano.2014.11.008. Epub 2015 Jan 14.

引用本文的文献

1
Quality-by-Design (QbD) Assisted Synthesis of Nanoparticle for Efficient Loading, Stabilization, and Intracellular Delivery of Bioactive for the Treatment of Arthritis.质量源于设计(QbD)辅助合成纳米颗粒用于生物活性物质的高效负载、稳定化及细胞内递送以治疗关节炎
Indian J Microbiol. 2025 Mar;65(1):477-504. doi: 10.1007/s12088-024-01338-y. Epub 2024 Jul 29.
2
Navigating Latency-Inducing Viral Infections: Therapeutic Targeting and Nanoparticle Utilization.应对潜伏期诱导性病毒感染:治疗靶点与纳米颗粒的应用
Biomater Res. 2024 Oct 16;28:0078. doi: 10.34133/bmr.0078. eCollection 2024.
3
Nanomedicine for the Treatment of Viral Diseases: Smaller Solution to Bigger Problems.
用于治疗病毒性疾病的纳米医学:解决大问题的更小方案。
Pharmaceutics. 2024 Mar 16;16(3):407. doi: 10.3390/pharmaceutics16030407.
4
Biomimetic Systems Involving Macrophages and Their Potential for Targeted Drug Delivery.涉及巨噬细胞的仿生系统及其在靶向药物递送方面的潜力。
Biomimetics (Basel). 2023 Nov 12;8(7):543. doi: 10.3390/biomimetics8070543.
5
Functionalizing Dendrimers for Targeted Delivery of Bioactive Molecules to Macrophages: A Potential Treatment for Infection-A Review.功能化树枝状大分子用于生物活性分子向巨噬细胞的靶向递送:一种潜在的感染治疗方法——综述
Pharmaceuticals (Basel). 2023 Oct 9;16(10):1428. doi: 10.3390/ph16101428.
6
Advancements of Nanotechnology and Nanomaterials in Environmental and Human Protection for Combatting the COVID-19 During and Post-pandemic Era: A Comprehensive Scientific Review.纳米技术和纳米材料在疫情期间及大流行后时代对抗COVID-19的环境与人类防护中的进展:全面科学综述
Biomed Mater Devices. 2023 May 10:1-24. doi: 10.1007/s44174-023-00086-9.
7
Therapeutic applications of nanobiotechnology.纳米生物技术的治疗应用。
J Nanobiotechnology. 2023 May 6;21(1):148. doi: 10.1186/s12951-023-01909-z.
8
Leveraging the therapeutic, biological, and self-assembling potential of peptides for the treatment of viral infections.利用肽的治疗、生物和自组装潜力治疗病毒感染。
J Control Release. 2022 Aug;348:1028-1049. doi: 10.1016/j.jconrel.2022.06.037. Epub 2022 Jul 6.
9
Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine.树枝状大分子在医学应用中的安全挑战与应用策略
Pharmaceutics. 2022 Jun 17;14(6):1292. doi: 10.3390/pharmaceutics14061292.
10
Novel Assay Platform to Evaluate Intracellular Killing of : and Validation.新型检测平台用于评估 和 对细胞内的杀伤作用:验证。
Front Immunol. 2021 Nov 12;12:750496. doi: 10.3389/fimmu.2021.750496. eCollection 2021.